Medical Device Network on MSN

Roche launches Axelios 1 sequencing platform

The launch was supported by collaborations with institutions such as the Hartwig Medical Foundation and Broad Clinical Labs.
We spoke to David Klenerman, co-developer of sequencing by synthesis, to find out how his work heralded the next generation ...
Ultima Genomics, Inc., a developer of ultra-high-throughput sequencing systems, continues its mission to enable sequencing at scale with the unveiling of the UG200 Series and next generation Solaris 2 ...
The landscape of next-generation sequencing (NGS) continues to be defined by astonishing technological progress. We continue to witness sequencer throughput expansion with systems like the Illumina ...
Natera NTRA announced the commercial launch of Zenith genomics, a next-generation whole genome sequencing assay designed to improve the detection and diagnosis of rare genetic diseases. The core ...
By Bhanvi Satija and Marleen Kaesebier LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing ...
AXELIOS 1 delivers a unique combination of accuracy, speed, scalability and cost efficiency, giving laboratories of all sizes the freedom to customise their workflows and explore a wider array of ...
Key challenges to developing "trans-tumor" targeted therapies are outlined in an editorial in the New England Journal of Medicine published Thursday by Fabrice André, head of the predictive biomarkers ...
Roche Holding AG is looking to take a share of Illumina Inc.’s dominance in the gene sequencing market with the launch of Axelios 1, its next-generation sequencing (NGS) platform designed for accuracy ...